Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia.

Martinez M, Frank A, Diez-Tejedor E, Hernanz A.

J Neural Transm Park Dis Dement Sect. 1993;6(1):1-9.

PMID:
8216758
2.

Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects.

Basun H, Forssell LG, Almkvist O, Cowburn RF, Eklöf R, Winblad B, Wetterberg L.

J Neural Transm Park Dis Dement Sect. 1990;2(4):295-304.

PMID:
2078309
3.
5.

Serum and cerebrospinal fluid cystatin C levels in vascular and Alzheimer's dementia.

Kálmán J, Márki-Zay J, Juhász A, Sántha A, Dux L, Janka Z.

Acta Neurol Scand. 2000 Apr;101(4):279-82.

PMID:
10770527
6.

Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.

Jia JP, Jia JM, Zhou WD, Xu M, Chu CB, Yan X, Sun YX.

Chin Med J (Engl). 2004 Aug;117(8):1161-4.

PMID:
15361288
7.

Amino acid concentration in dementia of the Alzheimer type and multi-infarct dementia.

Mochizuki Y, Oishi M, Hara M, Takasu T.

Ann Clin Lab Sci. 1996 May-Jun;26(3):275-8.

PMID:
8726221
8.

Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls.

Pirttilä T, Kim KS, Mehta PD, Frey H, Wisniewski HM.

J Neurol Sci. 1994 Dec 1;127(1):90-5.

PMID:
7699397
10.

Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia.

Parnetti L, Palumbo B, Cardinali L, Loreti F, Chionne F, Cecchetti R, Senin U.

Neurosci Lett. 1995 Jan 2;183(1-2):43-5.

PMID:
7746484
11.

Oligoclonal immunoglobulin bands in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.

Elovaara I, Seppälä I, Palo J, Sulkava R, Erkinjuntti T.

Acta Neurol Scand. 1988 May;77(5):397-401.

PMID:
3137767
12.

Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia.

Matsubara E, Hirai S, Amari M, Shoji M, Yamaguchi H, Okamoto K, Ishiguro K, Harigaya Y, Wakabayashi K.

Ann Neurol. 1990 Oct;28(4):561-7.

PMID:
2147546
13.

Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients.

Wada-Isoe K, Wakutani Y, Urakami K, Nakashima K.

Acta Neurol Scand. 2004 Aug;110(2):124-7.

PMID:
15242421
14.

Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy.

Schönknecht P, Pantel J, Hartmann T, Werle E, Volkmann M, Essig M, Amann M, Zanabili N, Bardenheuer H, Hunt A, Schröder J.

Psychiatry Res. 2003 Oct 15;120(3):231-8.

PMID:
14561434
15.
16.

Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia.

Yamada K, Kono K, Umegaki H, Yamada K, Iguchi A, Fukatsu T, Nakashima N, Nishiwaki H, Shimada Y, Sugita Y, et al.

Neurosci Lett. 1995 Feb 17;186(2-3):219-21.

PMID:
7777201
17.

Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease.

Kaye JA, May C, Atack JR, Daly E, Sweeney DL, Beal MF, Kaufman S, Milstien S, Friedland RP, Rapoport SI.

Ann Neurol. 1988 Nov;24(5):647-50.

PMID:
2462403
18.

No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia.

Arai H, Satoh-Nakagawa T, Higuchi M, Morikawa Y, Miura M, Kawakami H, Seki H, Takase S, Sasaki H.

Neurosci Lett. 1998 Nov 13;256(3):174-6.

PMID:
9855368
19.

CSF excitatory amino acids and severity of illness in Alzheimer's disease.

Csernansky JG, Bardgett ME, Sheline YI, Morris JC, Olney JW.

Neurology. 1996 Jun;46(6):1715-20.

PMID:
8649576
20.

Total tau in cerebrospinal fluid differentiates Alzheimer's disease from vascular dementia.

Leszek J, Małyszczak K, Janicka B, Kiejna A, Wiak A.

Med Sci Monit. 2003 Nov;9(11):CR484-8.

PMID:
14586274

Supplemental Content

Support Center